Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Caesars Entertainment
CZR
$6.08B
| $35.4M | 0.02% |
315,263
-1,574,695
| -83% | -$154M |
|
852
Phillips Edison & Co
PECO
$5.51B
| $35.4M | 0.02% |
+1,151,316
| New | +$33.8M |
|
853
CALL
Pinduoduo
PDD
$127B
| $35.4M | 0.02% |
389,900
+285,700
| +274% | +$27.8M |
|
854
Becton Dickinson
BDX
$46.4B
| $35.3M | 0.02% |
147,317
+31,627
| +27% | +$7.76M |
|
855
CALL
JD.com
JD
$44B
| $35.2M | 0.02% |
487,600
-173,200
| -26% | -$12.8M |
|
856
CALL
NextEra Energy
NEE
$185B
| $35.2M | 0.02% |
448,400
+377,800
| +535% | +$30.5M |
|
857
Dycom Industries
DY
$11.4B
| $35.2M | 0.02% |
494,038
+352,219
| +248% | +$24.9M |
|
858
Autodesk
ADSK
$52.4B
| $35.1M | 0.02% |
123,257
-128,478
| -51% | -$39.3M |
|
859
CALL
Philip Morris
PM
$312B
| $35.1M | 0.02% |
370,600
+105,900
| +40% | +$10.7M |
|
860
Woodward
WWD
$24B
| $35.1M | 0.02% |
310,114
+236,534
| +321% | +$28.1M |
|
861
CALL
iShares MSCI Brazil ETF
EWZ
$9.07B
| $34.9M | 0.02% |
1,087,100
| – | – |
|
862
Surgery Partners
SGRY
$2.14B
| $34.9M | 0.02% |
+823,891
| New | +$42M |
|
863
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.76B
| $34.9M | 0.02% |
881,400
+766,000
| +664% | +$31.8M |
|
864
RPM International
RPM
$13.8B
| $34.7M | 0.02% |
446,884
+300,790
| +206% | +$25.3M |
|
865
PJT Partners
PJT
$4.3B
| $34.6M | 0.02% |
437,217
+287,062
| +191% | +$22M |
|
866
PUT
O'Reilly Automotive
ORLY
$75.3B
| $34.6M | 0.02% |
849,000
+174,000
| +26% | +$6.96M |
|
867
PUT
Live Nation Entertainment
LYV
$42.7B
| $34.5M | 0.02% |
379,000
| – | – |
|
|
KRA
868
DELISTED
Kraton Corporation
KRA
| $34.5M | 0.02% |
756,203
+404,494
| +115% | +$16.1M |
|
869
SkinHealth Systems
SKIN
$85.1M
| $34.5M | 0.02% |
1,327,538
-107,517
| -7% | -$2.36M |
|
|
DNB
870
DELISTED
Dun & Bradstreet
DNB
| $34.3M | 0.02% |
2,042,400
-84,605
| -4% | -$1.61M |
|
|
SGEN
871
DELISTED
Seagen Inc. Common Stock
SGEN
| $34.3M | 0.02% |
201,759
-240,199
| -54% | -$37.4M |
|
872
EPR Properties
EPR
$4.88B
| $34.2M | 0.02% |
693,501
+500,823
| +260% | +$25.4M |
|
873
First Solar
FSLR
$21.8B
| $34.2M | 0.02% |
358,110
+75,373
| +27% | +$7M |
|
874
KBR
KBR
$4.51B
| $34.2M | 0.02% |
867,045
+112,152
| +15% | +$4.35M |
|
|
COUP
875
DELISTED
Coupa Software Incorporated
COUP
| $34.1M | 0.02% |
155,616
+24,049
| +18% | +$5.65M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.